Major players in the insulin pens, syringes, pumps, and injectors devices and equipment market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott, Insulet Corporation, Sanofi, Roche F.

New York, May 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2022" - https://www.reportlinker.com/p06277217/?utm_source=GNW Hoffmann-La Roche Ltd, Becton, Animas Corporation, and Ypsomed Holding AG. The global insulin pens, syringes, pumps and injectors market is expected to grow from $18.96 billion in 2021 to $20.98 billion in 2022 at a compound annual growth rate (CAGR) of 10.6%. The market is expected to grow to $29.79 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The insulin pens, syringes, pumps, and injectors devices and equipment market consists of sales of insulin pens, syringes, pumps and injectors, and related services.Insulin pens are reusable pen-like tools used to inject the desired dose of insulin into the blood of a diabetic patient. Insulin helps to ensure that glucose levels in the patient’s blood are appropriate.Insulin syringes are reusable devices used to inject insulin that is specifically made for self-administration. Insulin pumps and injectors are the devices that are used to deliver insulin continuously throughout the day to the diabetic patient and maintain blood glucose levels. The main types of insulin pens, syringes, pumps, and injectors devices and equipment are pens, injectors and pumps, syringes.The syringe is a device used to inject fluids into or withdraw them from something. The pens used are reusable and disposable.The pumps used are tubed pumps and tubeless pumps. The various end-users are hospitals, home care, and others. North America was the largest region in the insulin pens, syringes, pumps, and injectors devices and equipment market in 2021.Asia Pacific was the second largest market in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. An increase in the prevalence of diabetes globally is driving the growth of the insulin pens, syringes, pumps, and injectors market.The increase in the number of people suffering from obesity, unhealthy eating habits, physical inactivity, and the increasing geriatric population are some of the key factors which are leading to the increase in the global prevalence of diabetes. According to the US Centers for Disease Control and Prevention (CDC) in 2020, around 34.2 million people in the U.S. were suffering from diabetes. Also, according to the International Diabetes Federation, in 2019, globally approximately 463 million adults were living with diabetes; by 2045, this number would rise to 700 million, driving the insulin pens, syringes, pumps, and injectors market. Resistance towards self-injection by patients is restraining the insulin pens, syringes, pumps, and injectors market.The fear of injections causes anxiety in some patients thus causing them to avoid the use of insulin injections and being inconsistent in their insulin uptake. According to a report by, National Center for Biotechnology Information (NCBI) anxiety about and the fear of injection-associated pain has been estimated to affect approximately 30%–50% of patients, before the initiation of diabetes education interventions.The report also stated that close to 28% of patients were unwilling to initiate insulin therapy, if prescribed because they were not confident about handling the injections and the anticipated needle pain due to self-injection. This resistance to self-injection due to the fear of needles is hampering the growth of the market. Many companies are focusing on technological advancements in insulin delivery systems to deliver insulin effectively and safely.For instance, in February 2019, the FDA also approved the Tandem Diabetes Caret: Slim X2 insulin pump. This pump uses interoperable technology that allows patients to customize their diabetes management devices according to their preferences. These devices contain automated insulin dosing systems, continuous glucose monitors, blood glucose meters, or other electronic devices. The insulin pens, syringes, pumps, and injectors devices and equipment market is regulated by authorities such as the US FDA and European Medicines Agency.For instance, FDA’s Title 21 of the Code of Federal Regulations (CFR) provides guidelines for proper labeling of medical devices such as food, drugs, cosmetics, and other medical devices, the manufacturers of these devices must comply and adhere. FDA also provides strict label warnings prohibiting the sharing of insulin injectable medicines, to avoid infections in patients which are caused by the sharing of these insulin devices. In 2020, Medtronic, an Irish medical device company agreed to acquire Companion Medical, a manufacturer of InPen, for an undisclosed amount.The connected insulin pen helps users to manage their diabetes by tracking insulin doses and active insulin. This acquisition is an ideal strategic fit for Medtronic, to further simplify diabetes management and improve outcomes by optimizing dosing decisions for a large number of people using multiple daily injections (MDI). Companion Medical was founded by people with diabetes that fuels their drive to create insulin technologies that enable users to live their lives with diabetes solutions that make sense. The countries covered in the insulin pens, syringes, pumps, and injectors devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. Read the full report: https://www.reportlinker.com/p06277217/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

The Japanese investment bank began trading cryptocurrency derivative contracts this week, joining rivals including Goldman Sachs and JPMorgan in giving clients a way to access the crypto market.

(Reuters) -Elon Musk tweeted on Friday that his $44-billion cash deal for Twitter Inc was “temporarily on hold” while he waits for the social media company to provide data on the proportion of its fake accounts. Twitter shares initially fell more than 20% in premarket trading, but after Musk, the chief executive of electric car market Tesla Inc, sent a second tweet saying he remained committed to the deal, they regained some ground. The shares were down 9.6% to $40.71 in trading on Friday, a steep discount to the $54.20 per share acquisition price.

The pill has become an increasingly important tool in the nation’s defense against COVID-19 as mask mandates have lifted and people have returned to their non-distanced lives.

A controversial Calvin Klein ad is sparking dialogue about transgender pregnancies.

Crispr Therapeutics said Thursday it will unveil the first data from human studies of its gene-edited lymphoma drug — and CRSP stock popped.

The city's largest tech employer also said it will be offering counseling from Burlingame-based metal-health service provider Lyra Health.

Earlier in April, the Marijuana Opportunity Reinvestment and Expungement Act (MORE) was narrowly passed by the United States House of Representatives by a vote of 220-204. Marijuana use was legal until 29 U.S. states banned it between 1916 and 1931.

Intra-Cellular Therapies (NASDAQ: ITCI), a biotech that specializes in therapies to treat complex psychiatric and neurologic diseases, saw its shares rise 21.4% this week through today's close, according to data from S&P Global Market Intelligence. The drug was initially approved by the Food and Drug Administration (FDA) in the first quarter of 2020 as a treatment for adult schizophrenia. In late December, an additional indication, as a monotherapy or adjunct treatment for bipolar depression, was approved by the FDA.

Dr. Anthony Fauci, the nation’s top infectious disease specialist, told The Root today that cases of the deadly Covid-19 virus are slowly rising again across the country and warned that Black Americans could be particularly at risk in the event a more aggressive variant should appear. Fauci spoke with The Root this afternoon where he clarified his own comments about where the nation stood on the status of the pandemic as the country nears the milestone of 1 million deaths from the virus, which o

Paul Hennessy/SOPA Images/LightRocket via Getty A baby formula shortage has added to the woes of American parents already confronted with the pressures of raising an infant during a pandemic in a country ranked low for family-friendly policies.Media reports have highlighted the plight of mothers, fathers and caregivers across the U.S. who have scrambled to find scarce supplies, or driven long distances to buy formula.But what is behind the shortage? And how can it be prevented from happening aga

"I was in a medically induced coma for six weeks. There were times I was fully conscious, but I couldn't open my eyes, couldn't move a muscle, and couldn't speak. It was terrifying."View Entire Post ›

Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include fatigue, pain, neurological issues and even changes in mental health. Initially, public health officials believed that only a small minority of…

Ashley Judd is speaking out about mother Naomi Judd's cause of death — to get ahead of the news.

Biogen and development partner Eisai are looking to get their next Alzheimer's drug to market using the FDA's accelerated approval pathway.

Fiber has a lot to offer—it can support your gut health, help you lose weight or and even keep you feeling full for longer. To help you reap the benefits of getting enough fiber each day, these breakfasts include at least 6 grams of fiber per serving. Plus, each recipe focuses on complex carbs, like whole grains, and sticks to heart-healthy levels of saturated fat and sodium for a meal that fits perfectly into a diabetes-friendly routine.

Hepatitis C and HIV cost every taxpayer. Preventing new infections isn’t just an issue of health care — it also saves the public money. | Opinion

"Everybody's been asking like what it is I specifically did to get my body to this point," she said.

President Biden is scheduled to speak with retailers and manufacturers later Thursday about the ongoing efforts to resolve an infant formula supply shortage, a White House official said. The White House is also planning to announce “additional actions” the Biden administration is taking to address the shortage on Thursday, the official said. A nationwide shortage…

“This language, with a few buzzwords, is to keep some difficult, obstinate, conservative senators quiet,” said one Democratic representative.